Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics
in areas of unmet medical need.
Not exact matches
The Company manages over $ 100 million
of funds investing
in areas where true scientific innovations, the
unmet medical need, and the potential to demonstrate a significant proof
of concept all come together.
Chimerix, a biopharmaceutical company that develops antivirals
in areas of high
unmet medical need, announced
in a press release that a Phase 3 study for its SUPPRESS
of brincidofovir
in patients undergoing...
Collaborating with other academic researchers to advance clinical research
in areas of high
unmet medical need
Research at Roche is focusing on diseases with high
unmet medical need in the
areas of the central nervous system, genitourinary diseases, metabolic diseases, inflammation and bone diseases, oncology and vascular diseases as well as viral diseases.